Waiting for the NDA
resubmission news. Expecting the company presentation in 2020 BIO CEO
& Investor Conference on Feb 11, 2020, to cause the market to move upward.
In a possible future FDA approval for their IV oliceridine
drug will cause a nice Trend up. Holding all Longs and Share positions.